Apyx Medical (APYX) vs QTREX Quantum (QTEX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
QTREX Quantum (QTEX) has outperformed Apyx Medical (APYX) over the past year, gaining 9.3% versus a loss of 40.0%. Over five years, QTEX leads with a -69.7% price change compared with -83.4% for APYX. Apyx Medical is the larger company by market cap ($101.1 million vs $70.6 million), about 1.4 times the size.
Apyx Medical converts more of its revenue into profit, with a net margin of -21.2% versus -4574.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APYX | QTEX |
|---|---|---|
| Share price | $2.40 | $1.00 |
| Market cap | $101.10M | $70.63M |
| 1-day change | +0.42% | -10.71% |
| YTD return | -31.43% | +11.11% |
| 1-year return | -40.00% | +9.29% |
| 5-year return | -83.40% | -69.70% |
| EPS (TTM) | $-0.19 | $-0.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $52.84M | $289.00K |
| Revenue growth (YoY) | +9.86% | — |
| Net income (latest FY) | $-11.21M | $-13.22M |
| Gross margin | 62.53% | 0.69% |
| Operating margin | -12.20% | -4713.84% |
| Net margin | -21.22% | -4574.39% |
| 52-week high | $5.08 | $3.85 |
| 52-week low | $2.25 | $0.283 |
| Distance from 52-week high | -52.76% | -74.03% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +170.83% | +400.00% |
| Average volume | 146.81K | 9.21M |
| Shares outstanding | 42.12M | 70.63M |
| Employees | 205 | 34 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QTEX has outperformed APYX by 49.3 percentage points over the past year.
- Apyx Medical is more profitable, keeping -21.2 cents of every revenue dollar as net income versus -4574.4 cents for QTREX Quantum.
About Apyx Medical
APYX stock →Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM).
Health Care · Medical/Dental Instruments · 205 employees
About QTREX Quantum
QTEX stock →QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.
Health Care · Medical/Dental Instruments · 34 employees
APYX vs QTEX FAQ
Which is bigger, Apyx Medical or QTREX Quantum?
Apyx Medical (APYX) is larger, with a market capitalization of $101.10M compared with $70.63M for QTREX Quantum (QTEX).
Which stock has performed better over the past year, APYX or QTEX?
QTEX returned +9.29% over the past 12 months, compared with -40.00% for APYX (price return, excluding dividends). Past performance does not predict future results.
Are Apyx Medical and QTREX Quantum in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.